Lauge Schäffer - Researcher Profile

Publications

1 shown

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide

Jesper Lau , Paw Bloch , Lauge Schäffer +14 more

Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analogue that binds to serum albumin in vivo and is approved for once-daily treatment of diabetes as well as obesity. ...

2015 Journal of Medicinal Chemistry 923 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 1
Citations: 923
Institution: Novo Nordisk (Denmark)

External Links

Google Scholar

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.

Publications

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide

Frequent Co-Authors

Jesper Lau

Paw Bloch

Ingrid Pettersson

Jane C. Spetzler

Jacob Kofoed

Kjeld Madsen

Researcher Info

External Links

Impact Metrics

Academic Output Over Time